Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Liver Transplantation
100%
Hepatocellular Carcinoma
60%
Hepatectomy
45%
Model For End Stage Liver Disease Score
19%
Liver Graft
19%
Living Donor
18%
Survival Rate
17%
End Stage Liver Disease
15%
Cohort Analysis
15%
Neoplasm
15%
Piperidone Derivative
14%
Mycosis
14%
Maturity Onset Diabetes of the Young
14%
Cancer
14%
Overall Survival
14%
CD8 Antigen
12%
Liver Disease
10%
Proteasome
10%
Infection
10%
Hazard Ratio
9%
Propensity Score Matching
9%
Carcinoma
8%
Immunosuppressive Drug
8%
Long Term Survival
8%
Body Mass Index
8%
Ascites
8%
Hepatitis B
8%
Recurrence Risk
8%
Immunosuppressive Treatment
8%
Meta-Analysis
7%
Gastrointestinal Bleeding
7%
Common Hepatic Artery
7%
Fistula
7%
Omentectomy
7%
Underweight
7%
Scoring System
7%
Alternative Complement Pathway C3 C5 Convertase
7%
Nuclear Factor
7%
Cell Count
7%
Heterotopic
7%
Observational Study
7%
Betel
7%
Breast Cancer
7%
Hemodynamic
7%
All Cause Mortality
7%
Histamine Antagonist
7%
Barbed Suture
7%
Abdominal Cancer
7%
Blood Group ABO Incompatibility
7%
Postoperative Hemorrhage
7%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
53%
Maturity Onset Diabetes of the Young
22%
Piperidone Derivative
14%
N-Acetylcysteine
14%
Survival Rate
13%
Hepatitis B Virus
12%
Neoplasm
12%
Liver Disease
12%
Acute Graft Rejection
12%
Malignant Neoplasm
11%
Rituximab
11%
Proteasome
10%
Tacrolimus
9%
Ovary Cancer
9%
Head and Neck Cancer
9%
Recurrence Risk
9%
Hepatitis B
8%
Bortezomib
8%
End Stage Liver Disease
7%
Antihistaminic Agent
7%
Histamine H1 Receptor Antagonist
7%
Hernia
7%
Seroma
7%
Chronic Kidney Failure
7%
Vaccinia Vaccine
7%
Cisplatin
7%
Nuclear Factor
7%
Alternative Complement Pathway C3 C5 Convertase
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Decompensated Liver Cirrhosis
7%
Piper Betle
7%
Sodium Glucose Cotransporter 2 Inhibitor
7%
Blood Group ABO Incompatibility
7%
Virus Carrier
7%
Chronic Hepatitis C
7%
Matrix Metalloproteinase
7%
Leukemia
7%
Pharmacogenomics
7%
Ubiquitin
6%
Overall Survival
6%
Steroids
6%
Immunology and Microbiology
Cytotoxic T-Cell
37%
Liver Transplantation
37%
DNA Immunization
15%
Immune Tolerance
14%
DNA Vaccination
14%
Antigen Specificity
13%
Tumor Antigen
12%
Human Papillomavirus Type 16
9%
Immune Response
9%
Myeloid-Derived Suppressor Cell
9%
P53
9%
Electroporation
8%
Wart Virus
8%
Immunosuppression
8%
Survival Rate
7%
Mouse Model
7%
Viral Load
7%
CD4 CD8 Ratio
7%
Blood Group ABO Incompatibility
7%
Vaccinia Vaccine
7%
Body Mass
7%
T Cell Activation
7%
CD40 Ligand
7%
Agonist
7%
Imiquimod
7%
Hepatitis B
7%
Infectious Disease
7%
T Cell Exhaustion
7%
Radiofrequency
7%
Toll-Like Receptor
7%
Histone
7%
Propensity Score Matching
7%
Infection
7%
Antigen
6%
Rituximab
6%
Overall Survival
5%
Proteasome
5%